MatthewDouglasMerguerianMDPhD
Pediatric Hematology & Oncology • Baltimore, MDPediatric Anemia and Red Blood Cell Hematology, Pediatric Coagulation Disorder Hematology, Pediatric Platelet Disorder Hematology
Assistant Professor of Pediatric Hematology, Department of Pediatrics, Johns Hopkins University School of Medicine
Dr. Merguerian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 North Wolfe Street
Rubenstein BLDG Lower Level
Baltimore, MD 21287Phone+1 443-997-5437Fax+1 410-367-2748
Summary
- Dr. Matt Merguerian is a pediatric hematologist/oncologist in Baltimore, MD, and is affiliated with Johns Hopkins Hospital. He received his medical degree from Columbia University College of Physicians and Surgeons and has been in practice 8 years. He specializes in pediatric anemia, red blood cell disorders, coagulation disorders, and platelet disorders, and is experienced in general pediatrics, pediatric hematology, and pediatric oncology.
Education & Training
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2017 - 2020
National Cancer InstituteFellowship, Pediatric Hematology/Oncology, 2017 - 2020
Yale-New Haven Medical CenterResidency, Pediatrics, 2014 - 2017
Columbia University Vagelos College of Physicians and SurgeonsClass of 2014, MD, PhD
Certifications & Licensure
MD State Medical License 2017 - 2025- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 5 citationsGenomic landscape of patients with germline RUNX1 variants and familial platelet disorder with myeloid malignancy.Kai Yu, Natalie Deuitch, Matthew Merguerian, Lea Cunningham, Joie Davis
Blood Advances. 2024-01-23 - 7 citationsNatural history study of patients with familial platelet disorder with associated myeloid malignancy.Lea Cunningham, Matthew Merguerian, Katherine R Calvo, Joie Davis, Natalie T Deuitch
Blood. 2023-12-21 - 16 citationsExceptional response to the ALK and ROS1 inhibitor lorlatinib and subsequent mechanism of resistance in relapsed ALK F1174L-mutated neuroblastoma.Tingting Liu, Matthew D. Merguerian, Steven P. Rowe, Christine A. Pratilas, Allen R. Chen
Cold Spring Harbor Molecular Case Studies. 2021-08-01
External Links
- Faculty Profilehttps://www.hopkinsmedicine.org/matthew-merguerian
- LinkedInhttps://www.linkedin.com/in/merguerian/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
